Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tazarotene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tazarotene 0.1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 0.05% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 0.05% aqueous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 0.1% aqueous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 0.1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tazarotene 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tazarotene-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only tazarotene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tazarotene only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tazarotene 500 microgram/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tazarotene 500 microgram/mL cutaneous cream |
Has precise active ingredient |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing halobetasol and tazarotene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Halobetasol and tazarotene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tazarotene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |